Tenomix's mission is to develop novel technologies that target inefficiencies in the pathology workflow and optimize cancer care.
Tenomix has raised $367K in total funding. The most recent round was Grant. The last funding was announced in July 2024.
Tenomix's investors include Business Development Bank of Canada, Ontario Centre of Innovation, Archangel Network of Funds, TechAlliance of Southwestern Ontario, Ontario Bioscience Industry Organization.
Tenomix is headquartered in London, Canada.
Tenomix's mission is to develop novel technologies that target inefficiencies in the pathology workflow and optimize cancer care.
Tenomix is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Tenomix — Funding & Investors." VCBacked, July 8, 2024, https://www.vcbacked.co/company/tenomix. Accessed November 14, 2026.
VCBacked. (2024). Tenomix — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/tenomix
{{cite web |title=Tenomix — Funding & Investors |url=https://www.vcbacked.co/company/tenomix |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Tenomix? Request a listing update